Zobrazeno 1 - 10
of 24
pro vyhledávání: '"L. N. Shelikhova"'
Autor:
D. N. Balashov, L. N. Shelikhova, A. A. Demushkina, P. E. Trakhtman, Ye. V. Skorobogatova, D. V. Litvinov, Ye. V. Raykina, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 59-64 (2022)
Epstein–Barr virus (EBV) is a member of herpes-viruses family. Now it is well-known, that it can be a cause of wide spectrum lymphoproliferative disoders. The given problem is especially serious after hematopoietic stem cells transplantation (HSCT)
Externí odkaz:
https://doaj.org/article/6030623f2887490c92f3520939b1c2d8
Autor:
Y. V. Skvortsova, D. N. Balashov, Y. Y. Djakonova, Z. M. Dishlevaya, E. E. Kurnikova, N. V. Myakova, V. P. Nazhimov, E. V. Skorobogatova, L. N. Shelikhova, I. P. Shipitsina, P. E. Trakhtman, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 29-38 (2022)
Early complications of hematopoietic stem cell transplantation (HSCT) of vascular origin within the first 30-60 days after HSCT, which are resulting from endothelial injury, are an important cause of transplant-associated morbidity and mortality. Aut
Externí odkaz:
https://doaj.org/article/888b9597ef2e4a1fb703facfe3df5490
Autor:
D. N. Balashov, E. E. Kurnikova, M. A. Maschan, Yu. V. Skvortsov, L. N. Shelikhova, P. E. Trakhtman, E. V. Boyakova, E. V. Skorobogatova, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 9, Iss 4, Pp 24-27 (2015)
Unsuccessful mobilization of hematopoietic stem cells (HSCs) before apheresis in allograft donor is a factor adversely affecting the characteristics of the obtained cell product and, as a consequence, the therapy outcome. This study investigates the
Externí odkaz:
https://doaj.org/article/ec3d1750346445c9ab989905d94a64a9
Autor:
Ye. V. Samochatova, L. N. Shelikhova
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 30-34 (2014)
The article presents treatment results of 233 patients (children and adolescents under 19 years old; median — 8.76 years) with CD20-positive non-Hodgkin lymphomas and B-cell acute leukemia (B-NHL/B-AL) received chemotherapy (BFM B-NHL 90–95 proto
Externí odkaz:
https://doaj.org/article/cecdecb9191843c6b52d0aadb1b184de
Autor:
I. I. Kalinina, D. V. Litvinov, I. V. Veselova, N. I. Ponomareva, L. N. Shelikhova, V. V. Fominykh, G. A. Klyasova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 39-44 (2014)
Introduction: Invasive fungal infections (IFI) remain an unresolved issue of hematology/oncology despite the introduction of methods of early diagnostic and invent of new highly active antimycotics. In etiologic structure of IFI the leading role belo
Externí odkaz:
https://doaj.org/article/bd330a9adf8f4ccf83ffc01d9706fbee
Autor:
S. K. Arakelyan, S. L. Blagov, S. I. Kovrygin, A. A. Semchenkova, M. S. Fadeeva, D. A. Evseev, T. Yu. Salimova, D. D. Baidildina, L. N. Shelikhova, M. A. Maschan, A. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:104-112
Pure red cell aplasia (PRCA) is a rare complication of AB0-incompatible allogeneic hematopoietic stem cell transplantation, which manifests as a partial or complete absence of erythroid lineage in recipients with normal function of other hematopoieti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94e77c6c761e68bb38a43c5ce7f8091f
https://doi.org/10.24287/1726-1708-2023-22-2-104-112
https://doi.org/10.24287/1726-1708-2023-22-2-104-112
Autor:
T. V. Kudinova, Yu. V. Skvortsova, D. E. Bostanov, О. F. Lukina, E. A. Tikhomirova, D. N. Balashov, L. N. Shelikhova, A. F. Karelin
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:60-64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ce15aa3b83702d03b8bf35aeb550840
https://doi.org/10.24287/1726-1708-2023-22-2-60-64
https://doi.org/10.24287/1726-1708-2023-22-2-60-64
Autor:
D. A. Evstratov, A. D. Shutova, Yu. Yu. Dyakonova, S. A. Radygina, Yu. G. Abugova, L. Kh. Anderzhanova, L. A. Vavilova, D. V. Litvinov, G. A. Novichkova, A. M. Popov, V. V. Fominykh, L. A. Khachatryan, L. N. Shelikhova, N. V. Myakova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:46-52
Today, treatment results for acute lymphoblastic leukemia (ALL) look encouraging, yet 10–15% patients still end up relapsing. The success of relapse treatment is directly dependent on whether or not a tumor clone has been completely eradicated befo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3207d9eaa90510599657df2ed0d9d46c
https://doi.org/10.24287/1726-1708-2023-22-1-46-52
https://doi.org/10.24287/1726-1708-2023-22-1-46-52
Autor:
L. A. Vavilova, Yu. Yu. Dyakonova, O. I. Bydanov, N. V. Myakova, Yu. G. Abugova, L. Kh. Anderzhanova, D. A. Evstratov, E. E. Kurnikova, A. M. Popov, Yu. V. Olshanskaya, M. A. Maschan, L. N. Shelikhova, D. V. Litvinov, A. V. Popa, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:62-72
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Despite remarkable improvements in the treatment of pediatric acute lymphoblastic leukemia over last years, relapse still carries a poor prognosis with considerable morbidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ed935a04ba533aa4121b7f0900658cc
https://doi.org/10.24287/1726-1708-2023-22-1-62-72
https://doi.org/10.24287/1726-1708-2023-22-1-62-72
Autor:
D. V. Litvinov, I. P. Tesakov, L. N. Shelikhova, L. A. Khachatryan, E. A. Zerkalenkova, Yu. V. Olshanskaya, A. Yu. Komkov, A. M. Popov, E. V. Mikhaylova, A. N. Remizov, N. V. Myakova, Yu. V. Rumyantseva, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:100-114
Acute lymphoblastic leukemia (ALL) with translocation t(17;19)(q21-q22;p13) TCF3::HLF (E2A::HLF) accounts for less than 1% of childhood B-lineage ALL. Since the first description, patients with this type of ALL are stratified into high-risk group. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aec2a96dd7cb5690f86a0d870df79001
https://doi.org/10.24287/1726-1708-2022-21-3-100-114
https://doi.org/10.24287/1726-1708-2022-21-3-100-114